Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
about
Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in ThailandNo differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.Short-term clinical outcomes among treatment-experienced HIV-positive patients with early low level viremia.A model for reduced HIV-1 viral load monitoring in resource-limited settings.
P2860
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@en
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@nl
type
label
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@en
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@nl
prefLabel
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@en
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@nl
P2093
P2860
P356
P1476
Delaying a treatment switch in ...... ical Trials Group Study A5115.
@en
P2093
Alan L Landay
Allan R Tenorio
Barbara Bastow
Daniel R Kuritzkes
Hongyu Jiang
John A Bartlett
Sharon A Riddler
P2860
P304
P356
10.1089/AID.2008.0200
P577
2009-02-01T00:00:00Z